NCT04743635View on ClinicalTrials.gov

CONtrolled Focal Fibrous Band Release Method Study

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 7, 2021

Primary Completion Date

June 14, 2021

Study Completion Date

March 4, 2022

Conditions
Cellulite
Interventions
DEVICE

Avéli device

Minimally invasive single procedure with the Avéli device for reduction in the appearance of cellulite in the thighs and buttocks.

Trial Locations (9)

4215

Clinical Site #7, Southport

4350

Clinical Site #9, Toowoomba

33146

Clinical Site #2, Coral Gables

55441

Clinical Site #1, Minneapolis

71105

Clinical Site #6, Shreveport

90292

Clinical Site #3, Los Angeles

92121

Clinical Site #5, San Diego

94102

Clinical Site #4, San Francisco

02467

Clinical Site #8, Chestnut Hill

All Listed Sponsors
lead

Revelle Aesthetics, Inc

INDUSTRY

NCT04743635 - CONtrolled Focal Fibrous Band Release Method Study | Biotech Hunter | Biotech Hunter